Skip to main content
HYPR logo

HYPR · Hyperfine, Inc. · Webcasts, Transcripts & Audio

Track HYPR — free
$0.88 -0.01 (-1.22%) At close · Oct 5
Market Cap
$86.25M
Shares
106.05M
Volume · Oct 5 897.81K Avg daily vol (3M) 648.22K

Hyperfine, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Hyperfine, Inc. (HYPR), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-06
Hyperfine, Inc. (HYPR) Q2 2026 Earnings Call Transcript
Confident tone Product roadmap and software Financial performance and guidance Hospital and IDN adoption
Revenue
$3.90M
▲ 44.8% YoY
Diluted EPS
$-0.09
Gross margin
50.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Hyperfine, Inc. (HYPR) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-12
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
Confident tone Neurology office business Hospital and IDN business Revenue growth and financial performance
Revenue
$3.90M
▲ 82.6% YoY
Diluted EPS
$-0.09
Gross margin
50.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-18
Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript
Confident tone Next-generation Swoop system and Optive AI software Pipeline and deal momentum with IDNs Financial profile and balance sheet
Revenue
$5.29M*
▲ 128% YoY
Gross margin
50.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript
Confident tone Hospital vertical (ICUs, ERs, IDNs) Next-generation subsystem and Optive AI launch Guidance and 2026 outlook
Revenue
$3.44M
▼ 5.7% YoY
Diluted EPS
$-0.14
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Hyperfine, Inc. (HYPR) Q2 2025 Earnings Call Transcript
Confident tone Next-generation Swoop system launch Office setting / neurology clinic adoption Revenue and financial performance
Revenue
$2.70M
▼ 25.8% YoY
Diluted EPS
$-0.12
Gross margin
49.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Hyperfine, Inc. (HYPR) Q1 2025 Earnings Call Transcript
Balanced tone Office/neurology vertical launch Next-generation AI-powered image quality and software International growth and India entry
Revenue
$2.14M
▼ 35.1% YoY
Diluted EPS
$-0.12
Gross margin
41.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-11
Hyperfine, Inc. (HYPR) Q4 2024 Earnings Call Transcript
Positive tone Office channel expansion Hospital site expansion International growth
Revenue
$2.32M*
▼ 13.6% YoY
Gross margin
35.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
Confident tone Clinical Studies and Evidence Swoop System and Portable MRI AI-Powered Software Innovation
Revenue
$3.64M
▲ 56.4% YoY
Diluted EPS
$-0.14
Gross margin
52.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Hyperfine, Inc. (HYPR) Q2 2024 Earnings Call Transcript
Confident tone Alzheimer's / ARIA clinical program Revenue and commercial momentum New site placements (neurology offices, infusion centers)
Revenue
$3.63M
▲ 7.4% YoY
Diluted EPS
$-0.14
Gross margin
49.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Hyperfine, Inc. (HYPR) Q1 2024 Earnings Call Transcript
Confident tone International expansion via distributors ASP and revenue mix variability Alzheimer's clinical program (Care PMR)
Revenue
$3.29M
▲ 25% YoY
Diluted EPS
$-0.14
Gross margin
41.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-21
Hyperfine, Inc. (HYPR) Q4 2023 Earnings Call Transcript
Positive tone Alzheimer's opportunity Revenue growth and 2024 guidance Gross margin improvement
Revenue
$2.69M*
▲ 88.6% YoY
Gross margin
38.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Hyperfine, Inc. (HYPR) Q3 2023 Earnings Call Transcript
Revenue
$2.33M
▼ 0.8% YoY
Diluted EPS
$-0.15
Gross margin
48.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Hyperfine, Inc. (HYPR) Q2 2023 Earnings Call Transcript
Revenue
$3.38M
▲ 120.5% YoY
Diluted EPS
$-0.15
Gross margin
42.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Hyperfine, Inc. (HYPR) Q1 2023 Earnings Call Transcript
Revenue
$2.63M
▲ 74.6% YoY
Diluted EPS
$-0.17
Gross margin
43.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-21
Hyperfine, Inc. (HYPR) Q4 2022 Earnings Call Transcript
Revenue
$1.42M*
▲ 226.6% YoY
Gross margin
21.1%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Hyperfine, Inc. (HYPR) Q3 2022 Earnings Call Transcript
Revenue
$2.35M
▲ 532.9% YoY
Diluted EPS
$-0.19
Gross margin
29.3%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Hyperfine, Inc. (HYPR) Q2 2022 Earnings Call Transcript
Revenue
$1.53M
▲ 328.2% YoY
Diluted EPS
$-0.33
Gross margin
-10.8%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Hyperfine, Inc. (HYPR) Q1 2022 Earnings Call Transcript
Revenue
$1.51M
▲ 355.9% YoY
Diluted EPS
$-0.34
Gross margin
5.6%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-23
Hyperfine, Inc. (HYPR) Q4 2021 Earnings Call Transcript
Revenue
$436,000*
Gross margin
-103.9%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–20 of 20 webcasts
Key facts CIK 1833769 CUSIP 44916K106 13F (30d) 1 filings 1 filers Visit website Investor relations